Diagnóstico Y Manejo de Patologías Frecuentes en Caninos (Canis familiaris) Geriátricos (Revisión)
Abstract
There is a lack of information regarding the control and management of diseases in geriatric canine patients. This is mainly due to the fact that a great variety of them do not have a defined treatment, and are mostly chronic and progressive, decreasing the animal’s quality of life. Chronic kidney failure is the most common pathology in the geriatric stage; it is characterized by the deterioration of kidney function, accompanied by various secondary complications. This disease has a variety of markers for its diagnosis, with SDMA being the most precise; in terms of treatment, probiotics and medicated diets can be used to prevent its progress. On the other hand, canine cognitive dysfunction syndrome is considered an underdiagnosed disease, mainly due to the lack of diagnostic tests, therefore its evaluation will be based mostly on changes in behavior, caused by the accumulation of Aβ plaques in the brain, and the decrease in neurotransmitters. It is suggested that the management of this pathology can be carried out based on supplementation and diets that contain antioxidants and MTCs, and also through the use of selegiline, which is the only drug approved so far by the FDA for DCC. Finally, regarding Cushing’s syndrome, this pathology is also underdiagnosed, due to the fact that the clinical signs present are often confused with various diseases. Its management will be carried out based on pharmacological control, frequently with trilostane or mitotane; or through surgical interventions, mainly hypophysectomy or adrenalectomy, depending on the origin of the disease.
References
Alfonso, A., Le, A., Geraldes, S., Guimarães-Okamoto, P., Tsunemi, M., Santana, D., Ribeiro, V., Melchert, A., Chiacchio, S., Lourenço, M. (2020). Heart Rate Variability and Electrocardiographic Parameters Predictive of Arrhythmias in Dogs with Stage IV Chronic Kidney Disease Undergoing Intermittent Haemodialysis. Animals. 10(10):1829.
Alfredo, A., Ferrarin, D., Brito, R., Faria, J., Verardi, A., Mueller, E. (2020). Avaliação de um suplemento para animais idosos no tratamento de cães com sinais clínicos sugestivos da Síndrome da Disfunção Cognitiva Canina. Medicina Veterinária (UFRPE). 14(2):85-91.
Badino, P., Odore, R., Bergamasco, L., Barbero, R., Osella, M., D´Angelo, A., Re, G., Giarardi, C. (2013). Concentrations of platelet a2-adrenoceptors, lymphocyte muscarinic receptors, and blood monoamines in dogs (Canis familiaris) affected by canine cognitive dysfunction syndrome. Journal of Veterinary Behavior. 8(3):146-153.
Bartges, J. (2012). Chronic Kidney Disease in Dogs and Cats. Vet. Clin. Small Anim. (4):669–692.
Bennaim, M., Centola, S., Ramsey, I., Seth, M. (2019). Clinical and Clinicopathological Features in Dogs with Uncomplicated Spontaneous Hyperadrenocorticism Diagnosed in Primary Care Practice (2013–2014). JAAHA. 55(4):178-186.
Bennaim, M., Shiel, R., Forde, C., Mooney, C. (2018). Evaluation of individual low-dose dexamethasone suppression test patterns in naturally occurring hyperadrenocorticism in dogs. J Vet Intern Med. 32(3):967-977.
Beydoun, M., Beydoun, H., Hossain, S., El-Hajj, Z., Weiss, J., Zonderman, A. (2020). Clinical and Bacterial Markers of Periodontitis and Their Association with Incident All-Cause and Alzheimer´s Disease Dementia in a Large National Survey. Journal of Alzheimer’s Disease. 75(1):157-172.
Bloom, C., Labato, M. (2011). Intermittent Hemodialysis for Small Animals. Vet Clin Small Anim. 41(1):115-133.
Boghian, V. (2020). Clinical Biochemistry of Cushing Syndrome in Dogs. Rev. Chim. 71(3):320-324.
Carotenuto, G., Malerba, E., Dolfini, C., Brugnoli, F., Giannuzzi, P., Semprini, G., Tosolini, P., Fracassi, F. (2019). Cushing’s syndrome—an epidemiological study based on a canine population of 21,281 dogs. Open Veterinary Journal. 9(1):27-32.
Cianciolo, R., Benali, S., Aresu, L. (2015). Aging in the Canine Kidney. Veterinary Pathology. 53(2):299-308.
Çolakoğlu, E., Haydardedeoğlu, A., Alihosseini, A., Kurtdede, A. (2015). Mitotane-lnduced Hypoadrenocorticism in a Dog with Hyperadrenocorticism. Kafkas Univ Vet Fak Derg. 21(1):135-137.
Cowgill, L. (2011). Urea Kinetics and Intermittent Dialysis Prescription in Small Animals. Vet Clin Small Anim. 41(1):193-225.
Dahlem, D., Neiger, R., Schweighauser, A., Francey, T., Yerramilli, M., Obare, E., Steinbach, S. (2017). Plasma Symmetric Dimethylarginine Concentration in Dogs with Acute Kidney Injury and Chronic Kidney Disease. J Vet Intern Med. 31(3):799-804.
Das, M., Patra, R., Senapati, S., Rath, P. (2017). Haemato-Biochemical Alterations in the Geriatric Dogs with Chronic Kidney Disease. Indian Vet. J. 94(07):21-23.
Davies, M. (2012). Geriatric screening in first opinion practice – results from 45 dogs. Journal of Small Animal Practice. 53(9):507-513.
Davies, M. (2016). Focusing on geriatric pets. In Practice. 38(1):39-42.
Dewey, C., Davies, E., Xie, H., Wakshlad, J. (2019). Canine Cognitive Dysfunction Pathophysiology, Diagnosis, and Treatment. Vet Clin Small Anim. 49(3):477-499.
Dewey, C., Rishniw, M. (2021). Periodontal disease is associated with cognitive dysfunction in aging dogs: A blinded prospective comparison of visual periodontal and cognitive questionnaire scores. Open Veterinary Journal. 11(2):210-216.
Doerr, Outerbridge, C., White, S., Kass, P., Shiraki, R., Lam, A., Affolter, V. (2013). Calcinosis cutis in dogs: histopathological and clinical analysis of 46 cases. Vet Dermatol. 24(3):355-363.
Duarte, P., Cuadrado, A., León, R. (2020). Monoamine Oxidase Inhibitors: From Classic to New Clinical Approaches. Handbook of Experimental Pharmacology. 264:229-259.
Fiocchi, E., Cowgill, L., Brown, D., Markovich, J., Tucker, S., Labato, M., Callan, M. (2017). The Use of Darbepoetin to Stimulate Erythropoiesis in the Treatment of Anemia of Chronic Kidney Disease in Dogs. J Vet Intern Med. 31(2):476-485.
Galac, S. (2015). Selecting the Best Treatment Option for a Dog with Cushing´s Syndrome. Acta Veterinaria-Beograd. 65(1):1-19.
Geraldes, S., Sueur, A., Sant´Ana, P., Azevedo, M., Takahira, R., Melchert, A., Lourenço, M., Mamprim, M., Guimarães-Okamoto, P. (2019). The effect of intermittent hemodialysis on the hematological and serum biochemistry profile in dogs with chronic kidney disease. Topics in Companion Animal Medicine. 38:100389.
Gilor, C., Graves, T. (2011). Interpretation of Laboratory Tests for Canine Cushing’s Syndrome. Topics in Companion Animal Medicine. 26(2):98-108.
Hall, J., Fritsch, D., Yerramilli, M., Obare, E., Yerramilli, M., Jewell, D. (2017). A longitudinal study on the acceptance and effects of a therapeutic renal food in pet dogs with IRIS-Stage 1 chronic kidney disease. J Anim Physiol Anim Nutr. 102(1):297-307.
Hall, J., Yerramilli, M., Obare, E., Yerramilli, M., Almes, K., Jewell, D. (2016). Serum Concentrations of Symmetric Dimethylarginine and Creatinine in Dogs with Naturally Occurring Chronic Kidney Disease. J. Vet. Intern. Med. 30(3):794-802.
Hall, J., Yerramilli, M., Obare, E., Yerramilli, M., Melendez, L., Jewell, D. (2015). Relationship between lean body mass and serum renal biomarkers in healthy dogs. J Vet Intern Med. 29(3):808-814.
Han, S., Kim, J., Lee, J., Seo, K., Song, W., Ryu, M., Hwang, C., Youn, H. (2015). Renal Replacement Therapy of Chronic Kidney Disease with Uncontrolled Azotemia in Six Dogs. J Vet Clin. 32(5):440-444.
Hoffman, J., Lourenço, B., Promislow, D., Creevy, K. (2018). Canine hyperadrenocorticism associations with signalment, selected comorbidities and mortality within North American veterinary teaching hospitals. JSAP. 59(11):681-690.
International Renal Interest Society. (2019). IRIS Staging of CKD (modified 2019). [En línea]: International Renal Interest Society, (http://www.iris-kidney.com/guidelines/staging.html, 03 Jun. 2021).
Joubert, K. (2007). Pre-anaesthetic screening of geriatric dogs. Jl. S. Afr. Vet. Ass. 78(1): 31–35.
Kamer, A., Pushalkar, S., Gulivindala, D., Butler, T., Li, Y., Chowdary, K., Glodzik, L., Ballman, K., Corby, P., Blennow, K., Zetterberg, H., Saxena, D., Leon, M. (2021). Periodontal dysbiosis associates with reduced CSF Aβ42 in cognitively normal elderly. Alzheimer’s Dement. 13(1):e12172.
Karić, E., Hodžić, A., Zahirović, A., Hrković-Porobija, A., Ohran, H. (2021). Biochemical and haematological parameters in dogs with Cushing’s syndrome. Veterinarska Stanica. 52(4):413-419.
Kim, J., Lee, C. Kim, H. (2020). Biomarkers for chronic kidney disease in dogs: a comparison study. J. Vet. Med. Sci. 82(8):1130-1137.
Kooistra, H., Galac, S. (2012). Recent Advances in the Diagnosis of Cushing’s Syndrome in Dogs. Topics in Companion Animal Medicine. 27(1):21-24.
Koppe, L., Mafra, D., Fouque, D. (2015). Probiotics and chronic kidney disease. Kidney International. 88(5):958-966.
Kubinyi, E., Bel, S., Sándor, S., Szabó, A., Felföldi, T. (2020). Gut Microbiome Composition is Associated with Age and Memory Performance in Pet Dogs. Animals. 10(9):1488-1498.
Lamoureux, A., Da, F., Cappelle, J., Boulouis, H., Benchekroun, G., Cadoré, J., Krafft, E., Maurey, C. (2018). Frecuency of bacteriuira in dogs with chronic kidney disease: A retrospective study of 201 cases. J Vet Intern Med. 33(3):640-647.
Landsberg, G., Deporter, T., Araujo, J. (2011). Clinical Signs and Management of Anxiety, Sleeplessness, and Cognitive Dysfunction in the Senior Pet. Vet Clin North Am Small Anim Pract. 41(2011) 565–590.
Landsberg, G., Nichol, J., Araujo, J. (2012). Cognitive Dysfunction Syndrome A Disease of Canine and Feline Brain Aging. Vet Clin Small Anim. 42(4):749-768.
Lang, J., Schertel, E., Kennedy, S., Wilsn, D., Barnhart, M., Danielson, B. (2011). Elective and Emergency Surgical Management of Adrenal Gland Tumors: 60 Cases (1999–2006). JAAHA. 47(6):428-435.
Langston, C. (2016). Managing Fluid and Electrolyte Disorders in Kidney Disease. Vet Clin Small Anim. 47(2):471-490.
Larsen, J., Parks, E., Heinze, C., Fascetti, A. (2012). Evaluation of recipes for home-prepared diets for dogs and cats with chronic kidney disease. JAVMA. 240(5):532-538.
Mandelkow, E., Mandelkow, E. (2017). Biochemistry and Cell Biology of Tau Protein in Neurofibrillary Degeneration. Cold Spring Harb Perspect Med. 2(7):a006247.
Manteca, X. (2011). Nutrition and Behavior in Senior Dogs. Topics in Companion Animal Medicine. 26(1):33-36.
Melchert, A., Geraldes, S., Vieira, A., Takahira, R., Ramos, P., Barretti, P., Padovani, C., Sant’Ana, P., Ribeiro, J., Guimarães-Okamoto, P. (2017). Intermittent hemodialysis in dogs with chronic kidney disease stage III. Ciência Rural. 47(10):e20160900.
Metzger, F., Rebar, A. (2012). Clinical Pathology Interpretation in Geriatric Veterinary Patients. Vet Clin North Am Small Anim Pract. 42(4):615–629.
Nagata, N., Kojima, K., Yuki, M. (2016). Comparison of Survival Times for Dogs with Pituitary-Dependent Hyperadrenocorticism in a Primary-Care Hospital: Treated with Trilostane versus Untreated. J Vet Intern Med. 31(1):22-28.
Netsch, D. (2018). Calcinosis Cutis. JWOCN. 45(1):83-86.
O’Neill, D., Elliott, J., Church, D., Mcgreevy, P., Thomson, P., Brodbelt, D. (2013). Chronic Kidney Disease in Dogs in UK Veterinary Practices: Prevalence, Risk Factors, and Survival. J Vet Intern Med. 27(4):814-821.
Ozawa, M., Chambers, J., Uchida, K., Najayama, H. (2016). The relation between canine cognitive dysfunction and age-related brain lesions. J. Vet. Med. Sci. 78(6):997-1006.
Ozawa, M., Inoue, M., Uchida, K., Chambers, J., Takeuch, Y., Nakayama, H. (2019). Physical signs of canine cognitive dysfunction. J. Vet. Med. Sci. 81(12):1829-1834.
Pan, Y. (2011). Enhancing Brain Functions in Senior Dogs: A New Nutritional Approach. Topics in Companion Animal Medicine. 26(1):10-16.
Pan, Y., Landsberg, G., Mougeot, I., Kelly, S., Xu, H., Bhatnagar, S., Gardner, C., Milgram, N. (2018). Efficacy of a Therapeutic Diet on Dogs with Signs of Cognitive Dysfunction Syndrome (CDS): A Prospective Double Blinded Placebo Controlled Clinical Study. Front. Nutr. 12(5):127.
Polzin, D. (2011). Chronic Kidney Disease in Small Animals. Vet Clin Small Anim. 41(1):15-30.
Polzin, D. (2013). Evidence-based step-wise approach to managing chronic kidney disease in dogs and cats. Journal of Veterinary Emergency and Critical Care. 23(2):205-215.
Ribeiro, J., Liguori, T., Sueur, A., Padovani, C., Monteiro, M., Melchert, A., Guimarães-Okamoto, P. (2020). A Transversal Study of Biochemical Profile, Urinalysis, UPC, Electrolytes and Blood Pressure in Dogs with Chronic Kidney Disease. Acta Scientiae Veterinariae. 48:1733-1742.
Rishniw, M., Wynn, S. (2011). Azodyl, a symbiotic, fails to alter azotemia in cats with chronic kidney disease when sprinkled onto food. Journal of Feline Medicine and Surgery. 13(6):405-409.
Sanders, K., Kooistra, H., Galac, S. (2018). Treating canine Cushing’s syndrome: Current options and future Prospects. The Veterinary Journal. 241(2018):42-51.
Sargent, H., Elliott, J., Jepson, R. (2020). The new age of renal biomarkers: does SDMA solve all of our problems?. Journal of Small Animal Practice. 62(2):71-81.
Schmidt, F., Boltze, J., Jäger, C., Hofmann, S., Willems, N., Seeger, J., Härtig, W., Stolzing, A. (2015). Detection and Quantification of β-Amyloid, Pyroglutamyl Aβ, and Tau in Aged Canines. J Neuropathol Exp Neurol. 74(9):912-923.
Schofield, I., Brodbelt, D., Niessen, S., Church, D., Geddes, R., Kennedy, N., O´Neill, D. (2020). Development and internal validation of a prediction tool to aid the diagnosis of Cushing's syndrome in dogs attending primary-care practice. J Vet Intern Med. 34(6):2306-2318.
Schofield, I., O´Neill, D., Brodbelt, D., Church, D., Geddes, R., Niessen, S. (2019). Development and evaluation of a health-related quality-of-life tool for dogs with Cushing's syndrome. J Vet Intern Med. 33(6):2595-2604.
Schütt, T., Toft, N., Berendt, M. (2015). Cognitive Function, Progression of Age-Related Behavioral Changes, Biomarkers, and Survival in Dogs More Than 8 Years Old. J Vet Intern Med. 29(6):1569-1577.
Serrano-Pozo, A., Muzikansky, A., Gómez-Isla, T., Growdon, J., Betensky, R., Frosch, M., Hyman, B. (2013). Differential Relationships of Reactive Astrocytes and Microglia to Fibrillar Amyloid Deposits in Alzheimer Disease. J. Neuropathol. Expo. Neurol. 72(6):462-471.
Sieber-Rucksuhl, N., Burkhardt, W., Hofer-Inteeworn, N., Riond, B., Rast, T., Hofmann-Lehmann, R., Reusch, C., Boretti, F. (2015). Cortisol Response in Healthy and Diseased Dogs after Stimulation with a Depot Formulation of Synthetic ACTH. J Vet Intern Med. 29(6):1541-1546.
Stockman, J., Fascetti, A., Kass, P., Larsen, A. (2013). Evaluation of recipes of home-prepared maintenance diets for dogs. JAVMA. 242(11):1500-1505.
Sugimoto, K., Kozuka, T., Harada, S., Harada, T. (2020). Clinical Outcome of Azodyl Administration in Three Dogs with Chronic Kidney Disease. Intern J Appl Res Vet Med. 18(2):120-130.
Svicero, D., Thomas, M., Martins, R. (2017). Prevalence of behavioral changes in senile dogs. Ciência Rural. 47(2):e20151645.
Takahashi, R., Nagao, T., Gouras, G. (2017). Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer´s disease. Pathology International. 67(4):185-193.
Torres, M., Cruz, F., Silva, E., Poletto, D., Cayuela, M., Mendonça, A., Almeida, A., Sousa, V. (2017). Relation between anaemia and bone marrow features and serum erythropoietin in dogs with chronic kidney disease. Pesq. Vet. Bras. 37(6):598-602.
Ülgen, S., Bayrakal, A., Sargin, E., Akdoğan, A. (2015). The Changing Patterns in Referral Rates of Geriatric Cats and Dogs to a University Clinic. J. Fac. Vet. Med. Istanbul Univ. 41(2):232-237.
Van, S., Galac, S., Tryfonidou, M., Hesselink, J., Penning, L., Kooistra, H., Meij, B. (2016). The Influence of Pituitary Size on Outcome After Transsphenoidal Hypophysectomy in a Large Cohort of Dogs with Pituitary-Dependent Hypercortisolism. J Vet Intern Med. 30(4):989-995.
Wong, Y., Luk, K., Purtell, K., Burke, S., Stoessl, J., Trudeau, L., Yue, Z., Krainc, D., Oertel, W., Obeso, J., Volpicelli-Daley, L. (2019). Neuronal Vulnerability in Parkinson Disease: Should the Focus be on Axons and Synaptic Terminals?. Movement Disorders. 34(10):1406-1422.
Woolcock, A., Bugbee, A., Creevy, K. (2016). Evaluation of baseline cortisol concentration to monitor efficacy of twice-daily administration of trilostane to dogs with pituitary-dependent hyperadrenocorticism: 22 cases (2008–2012). JAVMA. 248(7):814-821.
Yu, C., Song, G., Yhee, J., Kim, J., Im, K., Nho, W., Lee, J., Sur, J. (2011). Histopathological and Immunohistochemical Comparison of the Brain of Human Patients with Alzheimer´s Disease and the Brain of Aged Dogs with Cognitive Dysfunction. J. Comp. Path. 145(1):45-58.
Zur, G., White, S. (2011). Hyperadrenocorticism in 10 Dogs with Skin Lesions as the Only Presenting Clinical Signs. JAAHA. 47(6):419-427.
